Company

We are revolutionizing the medical cannabis market.

We love cannabis. And we want to share that love with others. With high-quality therapies, new products and cannabis from all over the world.

We are passionate about good cannabis, at fair prices.

Medical cannabis is still far too expensive, especially for out-of-pocket patients. Yet high quality cannabis can be grown cost effectively in many parts of the world. We are bringing it to Europe. We guarantee this quality through our production process and pass on the price advantages to patients through low production costs and high volumes. Our declared goal: Everyone can afford his or her cannabis therapy - no matter if the costs are covered by the health insurance or as a out-of-pocket patient!

We stand for our global suppliers.

Why should it be reserved for a handful of large growers to offer medical cannabis  in Europe? With our platform, we eliminate bureaucratic hurdles for growers worldwide. So they can focus on what they do best: Grow great cannabis.

We are committed to destigmatizing cannabis.

With no other drug is the stigmatization of patients as prominent as with cannabis. We want to be a catalyst for change. We rely on personal responsibility instead of prohibition to limit abuse.

We provide an unpracedented variety of flowers.

Jamaica. Uruguay. New Zealand. Canada. Colombia. North Macedonia. Portugal. Uganda. All countries from which we have imported medical cannabis since mid-2021. Many more on the horizon...

We continue to create groundbraking products.

Our dronabinol solution - the first innovation on the German dronabinol market in 20 years - is just the beginning. We want to make it easier for patients, pharmacies and doctors to use medical cannabis.

We belive in our courage and creativity.

From the beginning, our team has shaped the topic of medical cannabis in Germany. Questioning the usual, breaking new ground, finding creative solutions - that's our DNA. We do what others don't think about.

we love cannabis

We love cannabis.
And we have for a long time.

How we have been shaping the topic of medical cannabis in Germany since the beginning

2015

2016

2017

2018

2019

2020

2021

2022

2023

Patrick Hoffmann and Florian Holzapfel found Pedanios GmbH, the first wholesaler of medical cannabis in Germany. At that time, only about 200 patients in Germany had a special permit to obtain medical cannabis flowers.

Pedanios imports cannabis flowers from Canada for the first time. Grower at the time: The Peace Naturals Project.

On March 10, the "Cannabis as Medicine" law comes into force, allowing doctors in Germany to prescribe cannabis for therapeutic purposes without indication. Within the next 12 months, the number of people treated with medical cannabis in Germany multiplies. From the beginning, Pedanios leads the rapidly growing market.

Pedanios GmbH is sold to the Canadian world market leader Aurora Cannabis Inc. and henceforth operates under the name Aurora Germany, today Aurora Europe.

The current Cantourage management team - back then still in the service of Aurora - wins the tender for cultivation of medical cannabis in Germany.

Florian and Patrick leave Aurora and found Cantourage GmbH together with Norman Ruchholtz, Constanze Pelzer and Mario Reichenbach.

Cantourage enters the German medical cannabis market with its own dronabinol product, breaking the monopoly that existed until then.

- Q2
Cantourage launches its "Fast Track Access" platform, which allows any licensed cannabis grower worldwide to bring their cannabis flower to Germany.

- Q3
For the first time, patients in Germany can be supplied with medical cannabis from Jamaica via Cantourage's platform.

- Q2
Cantourage opens its own cannabis clinic in London in order to be able to supply patients in the United Kingdom with medical cannabis from now on.

- Q2
With its self-developed dronabinol solution, Cantourage launches the first product innovation on the German dronabinol market in over 20 years.

- Q3
For the first time, Cantourage's medical cannabis is available in pharmacies for less than half the current black market price.

-Q4
Cantourage Group SE goes public on the Frankfurt Stock Exchange on November 11, 2022.

Cantourage launches its own telemedicine platform called “Telecan” in Germany to make it simplify access to cannabis therapy.

Executive board

Philip Schetter

CEO

Philip joined the cannabis industry in 2018: He was responsible for the construction of production facilities for Aurora in Europe and later served as CEO of Aurora Europe, responsible for the distribution of medical cannabis in 10 EU countries.

Constanze Pelzer

Director of Quality

Constanze is a pharmacist and has been working in the cannabis industry since 2016. As a co-founder, she has been an important part of Cantourage. She was responsible for obtaining all medicinal and narcotic permits and ensures that they are maintained.

Bernhard Retzer

Global Director of Sales

Bernhard started his career in the cannabis industry in 2018 at Aurora, where he founded subsidiaries in several countries. At Cantourage, he was responsible for the launch of the first Canadian Craft Cannabis in Germany.

Supervisory board

Dr. Michael Ruoff

Chairman

Doctor of law and graduate in business administration. In 2015, co-founded Think.Health Ventures, a boutique seed investor for startups in the German healthcare industry.

Patrick Hoffmann

Vice Chairman

After graduation, Patrick's mother predicted that he would either drive a cab or deal narcotics. Mom was right: in 2015 he founded Pedanios with Florian, and in 2019 Cantourage!

Dr. Florian Holzapfel

MBR of the Supervisory Board

Built up Pedanios GmbH, which was later sold to Aurora. Was a board member of a TecDAX company after his time at McKinsey. Founded Cantourage in 2019 with Patrick.

For us, cannabis means quality of life. That's why we are passionate about bringing the world's best cannabis to Germany. We are breaking new ground and using the potential of a dynamically developing industry.

we love cannabis - so do you?

Join our team and help us revolutionise Europe's cannabis market with your expertise.

we love cannabis - so do you?

What we offer

Creative freedom, active participation, personal and professional development. Step by step, we transfer more responsibility to you and adapt our internal development to your individual skills and goals.

We value flat hierarchies - but not anarchy.  Our management team supports you through feedback discussions at eye level.

see
open
positions

see open positions

Want to grow with us?

Take a look at our current job openings!Just click on the job title and you will be redirected to our career portal.  Who we are currently looking for:

Festanstellung, Vollzeit - Schwebheim

Talentpool

The right place for you!

Media about us

June 18, 2024

Zwischen Risiko und Nebenwirkungen - Sachsen nach der Cannabis-Legalisierung

June 14, 2024

„Mary Jane“ unterm Berliner Funkturm: Zwischen Business und Kiffer-Romantik auf der Cannabis-Messe

April 27, 2024

„Aberwitzige“ Preise für medizinisches Cannabis: „Deutlich günstiger als der Schwarzmarkt“

we love cannabis

Press releases /AD-HOC

November 20, 2024

New Sales Record: Cantourage Group SE Reports EUR 5.5 Million in Revenue for October 2024, Reaffirming Full-Year Growth Targets

November 7, 2024

Strong EBITDA growth: Cantourage Group SE posts EBITDA of EUR 1.4 million in third quarter of 2024 and sets course for further profitable growth

October 10, 2024

The medical cannabis market is booming: Cantourage Group SE reports record quarter in third quarter of 2024

September 4, 2024

Cantourage Group SE verzeichnet im Zeitraum Januar bis August 2024 höhere Umsatzerlöse als im Gesamtjahr 2023

July 9, 2024

Cantourage Group SE shows strong business performance and high growth momentum in the first half of 2024

Our cultivation partners

Our strain portfolio

Since 2019, we bring new cannabis strains from the world's best growers to Germany every month. Find out more about our current strains here.